4ZJW

RORgamma in complex with inverse agonist 16

Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.50 Å
  • R-Value Free: 0.250 
  • R-Value Work: 0.190 
  • R-Value Observed: 0.193 

wwPDB Validation   3D Report Full Report


This is version 1.2 of the entry. See complete history. 


Literature

Discovery of biaryl carboxylamides as potent ROR gamma inverse agonists.

Chao, J., Enyedy, I., Van Vloten, K., Marcotte, D., Guertin, K., Hutchings, R., Powell, N., Jones, H., Bohnert, T., Peng, C.C., Silvian, L., Hong, V.S., Little, K., Banerjee, D., Peng, L., Taveras, A., Viney, J.L., Fontenot, J.

(2015) Bioorg Med Chem Lett 25: 2991-2997

  • DOI: 10.1016/j.bmcl.2015.05.026
  • Primary Citation of Related Structures:  
    4ZJW, 4ZJR

  • PubMed Abstract: 

    • RORγt is a pivotal regulator of a pro-inflammatory gene expression program implicated in the pathology of several major human immune-mediated diseases. Evidence from mouse models demonstrates that genetic or pharmacological inhibition of RORγ activity can block the production of pathogenic cytokines, including IL-17, and convey therapeutic benefit ...

    RORγt is a pivotal regulator of a pro-inflammatory gene expression program implicated in the pathology of several major human immune-mediated diseases. Evidence from mouse models demonstrates that genetic or pharmacological inhibition of RORγ activity can block the production of pathogenic cytokines, including IL-17, and convey therapeutic benefit. We have identified and developed a biaryl-carboxylamide series of RORγ inverse agonists via a structure based design approach. Co-crystal structures of compounds 16 and 48 supported the design approach and confirmed the key interactions with RORγ protein; the hydrogen bonding with His479 was key to the significant improvement in inverse agonist effect. The results have shown this is a class of potent and selective RORγ inverse agonists, with demonstrated oral bioavailability in rodents.

    Organizational Affiliation: 

    Immunology Research, Biogen Idec, 12 Cambridge Center, Cambridge, MA 02142, United States.



Macromolecules
Find similar proteins by: 
(by identity cutoff)  |  Structure
Entity ID: 1
MoleculeChainsSequence LengthOrganismDetailsImage
Nuclear receptor ROR-gamma A, B225Homo sapiensMutation(s): 0 
Gene Names: RORC, NR1F3, RORG, RZRG
Find proteins for P51449 (Homo sapiens)
Explore P51449 
Go to UniProtKB:  P51449
NIH Common Fund Data Resources
PHAROS:  P51449
GTEx:  ENSG00000143365
Protein Feature View
Expand
  • Reference Sequence
Small Molecules
Ligands 1 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
4P1
Query on 4P1
Download Ideal Coordinates CCD File 
A
4-chloro-3-[1-(2-chloro-6-fluorobenzoyl)-1,2,3,4-tetrahydroquinolin-6-yl]-N-methylbenzamide
C24 H19 Cl2 F N2 O2
NWECRSKQCPBSPW-UHFFFAOYSA-N		 Ligand Interaction
External Ligand Annotations 
IDBinding Affinity (Sequence Identity %)
4P1IC50:  100   nM  BindingDB
4P1IC50:  100   nM  Binding MOAD
4P1EC50:  200   nM  BindingDB
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.50 Å
  • R-Value Free: 0.250 
  • R-Value Work: 0.190 
  • R-Value Observed: 0.193 
  • Space Group: C 1 2 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 125.586α = 90
b = 56.313β = 124.66
c = 79.517γ = 90
Software Package:
Software NamePurpose
REFMACrefinement
SCALAdata scaling
PDB_EXTRACTdata extraction
Cootmodel building
HKL-2000data reduction

Structure Validation

View Full Validation Report


View more in-depth experimental data

Entry History 

Deposition Data

  • Deposited Date: 2015-04-29 
  • Released Date: 2015-06-17 
    • Deposition Author(s): Marcotte, D.J.

Revision History  (Full details and data files)

  • Version 1.0: 2015-06-17
    Type: Initial release
  • Version 1.1: 2015-06-24
    Changes: Data collection
  • Version 1.2: 2017-11-01
    Changes: Author supporting evidence, Database references, Derived calculations, Source and taxonomy